Results for: Precision Medicine

September 29, 2017

Lab Director Raises $10 Million to Launch Private Development of Therapeutics for Autoimmune Disease

Biocomplexity Institute Lab Director Josep Bassaganya-Riera announced a successful round of Series A funding for his privately established biotherapeutics company. Landos Biopharma Inc. will develop treatments for Crohn’s disease and ulcerative colitis that could bring relief to the approximately 1.6 million American and 4 million global sufferers of IBD. 

July 17, 2017

Precision Medicine Could Help Patients Grappling with Life-threatening Intestinal Infections

Patients in long-term care facilities face an elevated risk of C. difficile infection, a life-threatening disease that could be managed more effectively with a precision medicine treatment plan.

June 28, 2017

Artificial Intelligence Aids Research to Find Best Treatment for Stroke Patients

Biocomplexity Institute researchers have teamed up with data experts at Geisinger Health to develop an artificial intelligence system that will help stroke victims receive treatment that suits their specific needs.

June 15, 2017

Researchers Uncover New Immunometabolic Target for Inflammatory Bowel Disease Treatments

Researchers at the Biocomplexity Institute of Virginia Tech have discovered a new therapeutic target for inflammatory bowel disease, and it’s right inside our immune cells: a gene known as NLRX1.

April 27, 2017

Personalized Healthcare Leader Receives Accolades

Josep Bassaganya-Riera, the director of a Leading Laboratory at the Biocomplexity Institute of Virginia Tech, won the 2017 Innovator Award presented by the Roanoke-Blacksburg Technology Council during its 18th annual TechNite Awards Dinner on April 21.

April 21, 2017

Research Shines Positive Light on Harmful Bacteria

Researchers at the Biocomplexity Institute of Virginia Tech are exploring why H. pylori bacteria are harmful to some people, while providing health benefits to others.

April 06, 2017

Successful Drug Trial Hints at Safer, More Effective Treatments for Flu

With hospitalizations estimated in the hundreds of thousands for influenza, research is more important than ever. Researchers at the Biocomplexity Institute of Virginia Tech’s Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have recently explored a new therapeutic target to treat flu infection.

March 20, 2017

Solving the Immunity Puzzle Takes Collaboration Among Different Fields

Studying the human immune system is like trying to work a vast, multidimensional jigsaw puzzle with pieces that are constantly changing shape. A recent paper in Trends in Immunology explores how technology is helping scientists arrive at faster, more effective solutions.

March 07, 2017

Molecular Alarm System Ensures Your Body’s First Response to an Attack Will be a Healthy One

If it’s not shut off at the appropriate time, the body's innate immune response can begin to spike at dangerous levels — a condition that’s been closely linked to heart disease, allergies, obesity, degenerative brain diseases, and cancer. Biocomplexity Institute researchers have discovered a molecular mechanism that keeps this reaction within healthy limits.

November 16, 2016

Discovery Could Take the Guesswork Out of When Meds Will Work Best

An international team of researchers, led by scientists at Virginia Tech, has just made the case for timely delivery of medication even more compelling. Their findings, recently released in Proceedings of the National Academy of Sciences, could vastly improve the effectiveness of common chemotherapy drugs and host of other time-dependent treatments.

October 10, 2016

TEDxVirginiaTech Speakers Will Share Ideas of Inspiration Nov. 10

In its fifth year, TEDxVirginiaTech will bring together Virginia Tech faculty, students, alumni, and members of the local community for a night of inspiring and thought-provoking ideas.

July 07, 2016

Advancing Precision Medicine: Computational Immunology for Next-Generation Healthcare

The Biocomplexity Institute is developing new research technologies that offer a promising alternative to the "one-size-fits-all" approach to wellness. Our approach to precision combines traditional wet lab studies with advanced computational modeling.